Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeys

NeuroReport

Volumn 7, Issue 2, 1996, Pages 565-568

  Matsuoka, Nobuya ^a,b   Aigner, Thomas G ^a,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b ASTELLAS PHARMA INC   (Japan)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

acetylcholine; glutamate; MK 801; monkeys; NMDA receptors; recognition memory; scopolamine

Indexed keywords

DIZOCILPINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CHOLINERGIC SYSTEM; CONTROLLED STUDY; MALE; MEMORY; MONKEY; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; VISUAL SYSTEM;

EID: 0029867042     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199601310-00045     Document Type: Article

References (24)

1. Aigner TG, Mitchell SJ, Aggleton JP et al. Psychopharmacology 92, 292-300 (1987).
2. Aigner TG and Mishkin M. Behav Neural Biol 45, 81-87 (1986).
3. Coyle JT, Price DL and DeLong MR. Science 219, 1184-1190 (1983).
4. Aigner TG, Mitchell SJ, Aggleton JP et al. Exp Brain Res 86, 18-26 (1991).
5. Dunnett SB and Fibiger HC. Prog Brain Res 98, 413-420 (1993).
6. Collingridge GL and Lester RAJ. Pharmacol Rev 40, 143-210 (1989).
7. Hollmann M and Heinemann S. Annu Rev Neurosci 17, 31-108 (1994).
8. Huntley GW, Vickers J and Morrison JH. Trends Neurosci 17, 536-543 (1994).
9. Bliss TVP and Collingridge GL. Nature 361, 31-39 (1993).
10. Sutor B and Hablitz J. Neurosci Lett 97, 111-117 (1989).
11. Morris RGM, Anderson E, Lynch GS et al. Nature 319, 774-776 (1986).
12. Morris RGM, Davis S and Buther SP. Hippocampal synaptic plasticity and N-methyl-D-aspartate receptors: a role in information storage. In: Baudry M and Davis JL, eds. Long-term Potentiation: The Debate of Current Issues. Cambridge, MA: MIT Press, 1991:267-301.
13. Whishaw IQ and Auer RN. Psychopharmacology 98, 500-507 (1989).
14. Ogura H and Aigner TG. J Pharmacol Exp Ther 266, 60-64 (1993).
15. Hasselmo ME. Behav Brain Res 67, 1-27 (1995).
16. Sahgal A. Psychopharmacology 91, 517-520 (1987).
17. Gebhard R, Zilles K, Schleicher A et al. Neuroscience 56, 877-885 (1993).
18. Storm-Mathisen J. Prog Neurobiol 8, 119-181 (1977).
19. Lehmann J and Scatton B. Brain Res 252, 77-89 (1982).
20. Nishimura LM and Boegman RJ. Neurosci Lett 115, 259-264 (1990).
21. Yamamoto C and Kawal N. Exp Neurol 19, 176-187 (1967).
22. Marchi M and Raiteri M. J Pharmacol Exp Ther 248, 1255-1260 (1989).
23. McCormick DA. Cellular mechanisms of cholinergic control of neocortical and thalamic neuronal excitability. In: Steriade M and Biesold D, eds. Brain Cholinergic Systems. Oxford: Oxford University Press, 1990: 236-263.
24. Markram H and Segal M. J Physiol 427, 381-393 (1990).